We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Ketorolac Tromethamine Injection

News List

Fresenius Kabi recalls 13 lots of ketorolac tromethamine injection europeanpharmaceuticalreview
April 24, 2020
The FDA has announced that Fresenius Kabi is voluntarily recalling 13 lots of ketorolac tromethamine injection due to particulate matter found in reserve sample vials.
Fresenius Kabi Issues Recall of 13 Lots of Ketorolac Tromethamine Injection americanpharmaceuticalreview
April 21, 2020
Fresenius Kabi is voluntarily recalling 13 lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1 mL fill in a 2 mL amber vial and ...
Hikma Extends Recall of Ketorolac Tromethamine Injection americanpharmaceuticalreview
March 09, 2020
Hikma Pharmaceuticals announces its subsidiary Hikma Pharmaceuticals USA Inc. (formerly known as West-Ward Pharmaceuticals) is voluntarily extending its previously-announced recall of ...